{"id":"NCT04333732","sponsor":"Washington University School of Medicine","briefTitle":"CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION","officialTitle":"An International, Multi-site, Bayesian Platform Adaptive, Randomized, Placebo-controlled Trial Assessing the Effectiveness of Candidate Agents in Mitigating COVID-19 Disease in Adults","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-09-04","primaryCompletion":"2021-08-10","completion":"2021-12-03","firstPosted":"2020-04-03","resultsPosted":"2024-03-26","lastUpdate":"2024-03-26"},"enrollment":3411,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["COVID 19"],"interventions":[{"type":"DRUG","name":"MR or M-M-R II ® vaccine","otherNames":["Merck"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"M-M-R II ®","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of CROWN CORONATION is the prevention of symptomatic COVID-19 by using combinations of approved and safe repurposed interventions, with complementary mechanisms of action.","primaryOutcome":{"measure":"Number of Participants With Symptomatic COVID-19 at 60 Days","timeFrame":"60 days after receiving trial intervention","effectByArm":[{"arm":"M-M-R II ®","deltaMin":24,"sd":null},{"arm":"Placebo","deltaMin":19,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.52"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":13},"locations":{"siteCount":17,"countries":["United States","Ghana","South Africa","United Kingdom","Zambia"]},"refs":{"pmids":["37153751","35713300","34473343"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":1722},"commonTop":[]}}